References
- 1. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. The American Journal of Medicine. 1959;27:375-388.10.1016/0002-9343(59)90003-8
- 2. Group JCSJW. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circulation Journal: Official Journal of the Japanese Circulation Society. 2010;74:1745-1762.10.1253/circj.CJ-10-74-0802
- 3. Ong P, Aziz A, Hansen HS, et al. Structural and Functional Coronary Artery Abnormalities in Patients With Vasospastic Angina Pectoris. Circulation Journal: Official Journal of the Japanese Circulation Society. 2015;79:1431-1438.10.1253/circj.CJ-15-0520
- 4. Tanabe Y, Itoh E, Suzuki K, et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. Journal of the American College of Cardiology. 2002;39:1120-1126.10.1016/S0735-1097(02)01746-1
- 5. Group JJW. Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina). Circulation Journal. 2010;74:1742-1762.
- 6. Hiki M, Tokano T, Nakazato Y, Daida H. Recurrent ventricular fibrillation under sufficient medical treatment in patient with coronary artery spasm. Case Reports. 2013; http://casereports.bmj.com/cgi/doi/2012007510.2012001136/bcr-2012002012-2012007583.10.1136/bcr-2012-007583373626023821622
- 7. Authors/Task Force m, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) * Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal. 2014;35:2541-2619.10.1093/eurheartj/ehu27825173339
- 8. Task Force M, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;34:2949-3003.10.1093/eurheartj/eht29623996286
- 9. Zeiher AM, Schächlinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation. 1994;89:2525-2532.10.1161/01.CIR.89.6.25258205660
- 10. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation. 1987;75:1110-1116.10.1161/01.CIR.75.6.11103568322
- 11. Tonino PAL, Sels J-WEM, Pijls NHJ. Invasive Physiological Assessment of coronary artery disease, in Eeckhout E, Serruys PW, Wijns W, Vahanian A, Van Sambeek M (eds): Percutaneous interventional cardiovascular medicine: the PCR-EAPCI textbook. 1. Europa éd, Toulouse. 2012;505-528.